|
Name |
5-(hydroxymethyl)-1H-pyrrole-2-carbaldehyde
|
| Molecular Formula | C6H7NO2 | |
| IUPAC Name* |
5-(hydroxymethyl)-1H-pyrrole-2-carbaldehyde
|
|
| SMILES |
C1=C(NC(=C1)C=O)CO
|
|
| InChI |
InChI=1S/C6H7NO2/c8-3-5-1-2-6(4-9)7-5/h1-3,7,9H,4H2
|
|
| InChIKey |
SRPREECLSOIPNK-UHFFFAOYSA-N
|
|
| Synonyms |
5-(hydroxymethyl)-1H-pyrrole-2-carbaldehyde; 67350-50-9; CHEBI:604731; 5-(hydroxymethyl)pyrrole-2-carboxaldehyde; 2-amino-6-(2-formyl-5-hydroxymethyl-1-pyrrolyl)-hexanoic acid; Epitope ID:141491; 2-Formyl-5-hydroxymethylpyrrol; CHEMBL499556; SCHEMBL17712572; DTXSID60497250; MFCD18810197; ZINC14491618; SB62063; AS-50199; CS-0157346; EN300-364250; O11303; 1H-Pyrrole-2-carboxaldehyde,5-(hydroxymethyl)-(9ci); Q27225782
|
|
| CAS | 67350-50-9 | |
| PubChem CID | 12416228 | |
| ChEMBL ID | CHEMBL499556 |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 125.13 | ALogp: | -0.3 |
| HBD: | 2 | HBA: | 2 |
| Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 53.1 | Aromatic Rings: | 1 |
| Heavy Atoms: | 9 | QED Weighted: | 0.572 |
| Caco-2 Permeability: | -4.524 | MDCK Permeability: | 0.00001460 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
| Human Intestinal Absorption (HIA): | 0.01 | 20% Bioavailability (F20%): | 0.003 |
| 30% Bioavailability (F30%): | 0.025 |
| Blood-Brain-Barrier Penetration (BBB): | 0.762 | Plasma Protein Binding (PPB): | 18.55% |
| Volume Distribution (VD): | 1.017 | Fu: | 84.13% |
| CYP1A2-inhibitor: | 0.294 | CYP1A2-substrate: | 0.103 |
| CYP2C19-inhibitor: | 0.043 | CYP2C19-substrate: | 0.065 |
| CYP2C9-inhibitor: | 0.008 | CYP2C9-substrate: | 0.448 |
| CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.468 |
| CYP3A4-inhibitor: | 0.007 | CYP3A4-substrate: | 0.167 |
| Clearance (CL): | 6.49 | Half-life (T1/2): | 0.917 |
| hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.085 |
| Drug-inuced Liver Injury (DILI): | 0.091 | AMES Toxicity: | 0.043 |
| Rat Oral Acute Toxicity: | 0.164 | Maximum Recommended Daily Dose: | 0.013 |
| Skin Sensitization: | 0.205 | Carcinogencity: | 0.031 |
| Eye Corrosion: | 0.119 | Eye Irritation: | 0.99 |
| Respiratory Toxicity: | 0.969 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001019 | ![]() |
0.389 | D0E9CD | ![]() |
0.250 | ||
| ENC000005 | ![]() |
0.282 | D05OIS | ![]() |
0.231 | ||
| ENC000166 | ![]() |
0.282 | D08ZEB | ![]() |
0.191 | ||
| ENC000412 | ![]() |
0.270 | D0Y7DP | ![]() |
0.183 | ||
| ENC000748 | ![]() |
0.268 | D07HBX | ![]() |
0.182 | ||
| ENC000696 | ![]() |
0.268 | D0C6OQ | ![]() |
0.179 | ||
| ENC000068 | ![]() |
0.250 | D01CRB | ![]() |
0.176 | ||
| ENC000003 | ![]() |
0.250 | D0V9EN | ![]() |
0.176 | ||
| ENC000414 | ![]() |
0.250 | D0S2BV | ![]() |
0.175 | ||
| ENC004043 | ![]() |
0.245 | D05EJG | ![]() |
0.175 | ||